Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)

Attention deficits are among the most common and persistent impairments resulting from traumatic brain injury (TBI). This study was the first to examine the effects of lisdexamfetamine dimesylate (LDX, Vyvanse) in treating TBI-related attention deficits in children. It was an extension of a previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Tramontana, Michael G., Prokop, Jonathan W., Williamson, Edwin, Duffie, Tara, LaFever, Hayden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830684/
https://www.ncbi.nlm.nih.gov/pubmed/33467178
http://dx.doi.org/10.3390/brainsci11010117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830684/
https://www.ncbi.nlm.nih.gov/pubmed/33467178
http://dx.doi.org/10.3390/brainsci11010117

Ejemplares similares